Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-small Cell Lung Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT01441128
What this trial is testing

-02341066 and PF-00299804 for Advanced Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small Cell LungAdenocarcinomaCarcinoma, Squamous Cell+1 more
National Cancer Institute (NCI) 20
Early research (Phase 1)Active Not RecruitingNCT06447662
What this trial is testing

Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.

Who this might be right for
Carcinoma, Pancreatic DuctalColorectal NeoplasmsCarcinoma, Non-Small-Cell Lung
Pfizer 64
Testing effectiveness (Phase 2)Study completedNCT00264433
What this trial is testing

The Safety and Effects of ADH-1 Given Intravenously as a Single Agent

Who this might be right for
Neoplasms
Adherex Technologies, Inc.
Not applicableStudy completedNCT01603849
What this trial is testing

Prophylactic Cranial Irradiation in Patients With Lung Adenocarcinoma With High Risk of Brain Metastasis

Who this might be right for
Lung Cancer
Instituto Nacional de Cancerologia de Mexico 84
Testing effectiveness (Phase 2)Study completedNCT00411047
What this trial is testing

Gefitinib in Treating Patients With Previously Untreated Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Massachusetts General Hospital 34
Testing effectiveness (Phase 2)UnknownNCT06519110
What this trial is testing

Neratinib Tablets Monotherapy for Advanced Solid Tumors With HER2 Mutations

Who this might be right for
Advanced Solid Tumor
Convalife (Shanghai) Co., Ltd. 60
Early research (Phase 1)Study completedNCT00004879
What this trial is testing

Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction Cancer

Who this might be right for
Colorectal CancerEsophageal CancerKidney Cancer+3 more
Jonsson Comprehensive Cancer Center
Not applicableLooking for participantsNCT06899789
What this trial is testing

Long-term Follow-up of Checkpoint Inhibitors-induced Ileo-colitis

Who this might be right for
Immune Checkpoint Inhibitors-induced ColitisAdvanced Melanoma Skin Cancer, Non-small Cell Lung Carcinoma, Kidney AdenocarcinomaIleo-colitis+1 more
Fondazione IRCCS Policlinico San Matteo di Pavia 250
Early research (Phase 1)Ended earlyNCT02650635
What this trial is testing

TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients With Metastatic, Persistent, Recurrent, or Progressive Solid Tumors

Who this might be right for
Colorectal AdenocarcinomaMetastatic Pancreatic AdenocarcinomaRecurrent Breast Carcinoma+14 more
Mayo Clinic 4
Early research (Phase 1)Looking for participantsNCT04147078
What this trial is testing

Personalized DC Vaccine for Postoperative Cancer

Who this might be right for
Gastric CancerHepatocellular CarcinomaNon-Small-Cell Lung Cancer+1 more
Sichuan University 80
Testing effectiveness (Phase 2)Looking for participantsNCT06281678
What this trial is testing

IBI363 in Subjects with Advanced Solid Malignancies

Who this might be right for
MelanomaNon-small Cell Lung CancerColorectal Cancer+1 more
Innovent Biologics (Suzhou) Co. Ltd. 178
Large-scale testing (Phase 3)Study completedNCT00003685
What this trial is testing

Radiation Therapy to Relieve Symptoms in Patients With Non-small Cell Lung Cancer

Who this might be right for
FatigueLung CancerNausea and Vomiting+3 more
NCIC Clinical Trials Group 230
Not applicableStudy completedNCT00310115
What this trial is testing

Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy

Who this might be right for
Bladder CancerCervical CancerEsophageal Cancer+8 more
M.D. Anderson Cancer Center 469
Large-scale testing (Phase 3)Ended earlyNCT02231164
What this trial is testing

LUME-Columbus: Nintedanib Plus Docetaxel in Advanced Non-small Cell Lung Cancer With Translational Research

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 12
Testing effectiveness (Phase 2)Study completedNCT00354549
What this trial is testing

Bevacizumab and Erlotinib Followed by Cisplatin or Carboplatin and Gemcitabine in Treating Patients With Newly Diagnosed or Recurrent Stage IIIB or Stage IV NSCLC

Who this might be right for
Lung Cancer
Swiss Cancer Institute 104
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07482605
What this trial is testing

Furmonertinib Plus Radiotherapy for EGFR+ NSCLC With Pleural Effusion

Who this might be right for
Lung Cancer (NSCLC)Malignant Pleural Effusions (Mpe)- Pleurodesis
Jiangmen Central Hospital 63
Testing effectiveness (Phase 2)Study completedNCT01577654
What this trial is testing

Phase 2 Study of EC145 Alone Versus EC145+Docetaxel Versus Docetaxel Alone in Participants With FR(++) 2nd Line Non Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Endocyte 203
Testing effectiveness (Phase 2)Looking for participantsNCT04977453
What this trial is testing

GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorCervical Cancer+3 more
GI Innovation, Inc. 317
Early research (Phase 1)Active Not RecruitingNCT05789069
What this trial is testing

HFB200603 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors

Who this might be right for
Renal Cell CarcinomaMelanomaNon Small Cell Lung Cancer+2 more
HiFiBiO Therapeutics 83
Testing effectiveness (Phase 2)Active Not RecruitingNCT02713269
What this trial is testing

Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord

Who this might be right for
Malignant Digestive System NeoplasmMetastatic Head and Neck CarcinomaMetastatic Kidney Carcinoma+10 more
M.D. Anderson Cancer Center 60
Next Page